1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	686_QUEST_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0332285	atributo	6-8	686_QUEST_clinical_caseMIR	SENT1	-	-
3	16	16		-	-	9-11	686_QUEST_clinical_caseMIR	SENT1	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	686_QUEST_clinical_caseMIR	SENT1	-	-
5	que	que	PR0CN000	-	-	17-20	686_QUEST_clinical_caseMIR	SENT1	-	-
6	inicia	iniciar	VMIP3S0	-	-	21-27	686_QUEST_clinical_caseMIR	SENT1	-	-
7	seguimiento	seguimiento	NCMS000	-	-	28-39	686_QUEST_clinical_caseMIR	SENT1	-	-
8	en	en	SPS00	C1720294#C0332285	calificador#atributo	40-42	686_QUEST_clinical_caseMIR	SENT1	-	-
9	la	el	DA0FS0	-	-	43-45	686_QUEST_clinical_caseMIR	SENT1	-	-
10	consulta	consulta	NCFS000	C3543841#C0009818	metadato_fundacional#procedimiento	46-54	686_QUEST_clinical_caseMIR	SENT1	-	-
11	de	de	SPS00	C0332285	atributo	55-57	686_QUEST_clinical_caseMIR	SENT1	-	-
12	Neurología	neurología	NCFS000	C0027855	calificador	58-68	686_QUEST_clinical_caseMIR	SENT1	-	-
13	de	de	SPS00	C0332285	atributo	69-71	686_QUEST_clinical_caseMIR	SENT1	-	-
14	adultos	adulto	NCMP000	C0001675	persona	72-79	686_QUEST_clinical_caseMIR	SENT1	-	-
15	,	,	Fc	-	-	79-80	686_QUEST_clinical_caseMIR	SENT1	-	-
16	remitida	remitir	VMP00SF	C0439600	calificador	81-89	686_QUEST_clinical_caseMIR	SENT1	-	-
17	desde	desde	SPS00	-	-	90-95	686_QUEST_clinical_caseMIR	SENT1	-	-
18	Neuropediatría	neuropediatría	NCFS000	-	-	96-110	686_QUEST_clinical_caseMIR	SENT1	-	-
19	con	con	SPS00	C0332287	atributo	111-114	686_QUEST_clinical_caseMIR	SENT1	-	-
20	el	el	DA0MS0	-	-	115-117	686_QUEST_clinical_caseMIR	SENT1	-	-
21	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	118-129	686_QUEST_clinical_caseMIR	SENT1	-	-
22	de	de	SPS00	C0332285	atributo	130-132	686_QUEST_clinical_caseMIR	SENT1	-	-
23	epilepsia	epilepsia	NCFS000	C0270853_1	trastorno_1	133-142	686_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
24	mioclónica	mioclónica		C0270853_2	trastorno_2	143-153	686_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
25	juvenil	juvenil	NCCS000	C0270853_3	trastorno_3	154-161	686_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
26	(	(	Fpa	-	-	162-163	686_QUEST_clinical_caseMIR	SENT1	-	-
27	EMJ	emj	NCMS000	-	-	163-166	686_QUEST_clinical_caseMIR	SENT1	-	-
28	)	)	Fpt	-	-	166-167	686_QUEST_clinical_caseMIR	SENT1	-	-
29	.	.	Fp	-	-	167-168	686_QUEST_clinical_caseMIR	SENT1	-	-

1	Está	estar	VAM02S0	-	-	169-173	686_QUEST_clinical_caseMIR	SENT2	-	-
2	en	en	SPS00	C1720294#C0332285	calificador#atributo	174-176	686_QUEST_clinical_caseMIR	SENT2	-	-
3	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	177-188	686_QUEST_clinical_caseMIR	SENT2	-	-
4	con	con	SPS00	C0332287	atributo	189-192	686_QUEST_clinical_caseMIR	SENT2	-	-
5	ácido	ácido	NCMS000	C0042291_1	sustancia_1	193-198	686_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
6	valproico	valproico		C0042291_2	sustancia_2	199-208	686_QUEST_clinical_caseMIR	SENT2	I-Grp_Medicamento	-
7	y	y	CC	C1706368	calificador	209-210	686_QUEST_clinical_caseMIR	SENT2	-	-
8	bien	bien	RG	C0205170	calificador	211-215	686_QUEST_clinical_caseMIR	SENT2	-	-
9	controlada	controlar	VMP00SF	-	-	216-226	686_QUEST_clinical_caseMIR	SENT2	-	-
10	.	.	Fp	-	-	226-227	686_QUEST_clinical_caseMIR	SENT2	-	-

1	Se	se	P00CN000	-	-	228-230	686_QUEST_clinical_caseMIR	SENT3	-	-
2	plantearía	plantear	VMIC3S0	-	-	231-241	686_QUEST_clinical_caseMIR	SENT3	-	-
3	hacer	hacer	VMN0000	-	-	242-247	686_QUEST_clinical_caseMIR	SENT3	-	-
4	alguna	alguno	DI0FS0	C0205392	calificador	248-254	686_QUEST_clinical_caseMIR	SENT3	-	-
5	modificación	modificación	NCFS000	-	-	255-267	686_QUEST_clinical_caseMIR	SENT3	-	-
6	en	en	SPS00	C1720294#C0332285	calificador#atributo	268-270	686_QUEST_clinical_caseMIR	SENT3	-	-
7	su	su	DP3CS0	-	-	271-273	686_QUEST_clinical_caseMIR	SENT3	-	-
8	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	274-285	686_QUEST_clinical_caseMIR	SENT3	-	-
9	.	.	Fp	-	-	285-286	686_QUEST_clinical_caseMIR	SENT3	-	-

